Emergency Contraception in Israel

July 2013 | 19 pages | ID: EDBD0225D66EN
Euromonitor International Ltd

Abstracts

In December 2010, a new brand entered the Israeli market, ending the 10-year dominance of the Postinor brand marketed by Trima. The new brand, NorLevo, was launched by CTS and stimulated the competitive environment and led to positive growth in 2011. This launch was among the most significant in the consumer health market, as emergency contraception is a very sensitive type of product, with the category previously having been dominated by a single brand. This brand, Postinor became a generic...

Euromonitor International's Emergency Contraception in Israel report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Emergency Contraception market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Emergency Contraception: Value 2007-2012
  Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
  Table 3 Emergency Contraception Company Shares by Value 2008-2012
  Table 4 Emergency Contraception Brand Shares by Value 2009-2012
  Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
  Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Executive Summary
Slower Growth for Consumer Health in 2012 Compared To the Review Period
Ministry of Health Warns Against Use of Vitamin A
Teva Pharmaceutical Sustains Its Lead
Healthfood Shops Gain Share Thanks To the Popularity of Vds
Higher Growth for Consumer Health Over the Forecast Period
Key Trends and Developments
Health Trend in Medicines Takes Hold As Consumers Avoid Chemicals
Consumers Are Highly Influenced by Mass Media
Israeli Ministry of Health Is Highly Influenced by Studies and World Trends
Private Label Products Shows Signs of Growth
Lack of Price Regulation in Vds Leads the Ministry of Health To Make Changes
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Penetration of Private Label by Category 2007-2012
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Registration and Classification of Vitamins and Dietary Supplements
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC: Switches 2010-2012
Definitions
Sources
Summary 2 Research Sources